These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30267712)

  • 41. Hepatitis C virus infection: co-infection with HIV and HBV.
    Cropley I; Main J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):265-75. PubMed ID: 10890321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual hepatitis virus infections in liver transplant: case report and a review of the literature.
    Yataco ML; Dickson RC; Bonatti H; Aranda-Michel J; Mendez J; Ghabril M; Nguyen J
    Clin Transplant; 2009; 23(2):282-8. PubMed ID: 19191801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mathematical model of immune response to hepatitis B.
    Fatehi Chenar F; Kyrychko YN; Blyuss KB
    J Theor Biol; 2018 Jun; 447():98-110. PubMed ID: 29574141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
    Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
    Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shared immunotherapeutic approaches in HIV and hepatitis B virus: combine and conquer.
    Maini MK; Peppa D
    Curr Opin HIV AIDS; 2020 May; 15(3):157-164. PubMed ID: 32167944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host-virus interactions in hepatitis B virus infection.
    Guidotti LG; Isogawa M; Chisari FV
    Curr Opin Immunol; 2015 Oct; 36():61-6. PubMed ID: 26186123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute coinfection with hepatitis B and hepatitis C viruses.
    Yan BM; Lee SS
    Can J Gastroenterol; 2005 Dec; 19(12):729-30. PubMed ID: 16341313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.
    Li X; Liu X; Tian L; Chen Y
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):41-54. PubMed ID: 25480494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hepatitis B infection in children].
    Christensen VB; Nordly S; Kjær M; Jørgensen MH
    Ugeskr Laeger; 2014 Apr; 176(8):. PubMed ID: 25096461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Viral-Associated GN: Hepatitis B and Other Viral Infections.
    Kupin WL
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune Response in Hepatitis B Virus Infection.
    Tan A; Koh S; Bertoletti A
    Cold Spring Harb Perspect Med; 2015 Jul; 5(8):a021428. PubMed ID: 26134480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The host-pathogen interaction during HBV infection: immunological controversies.
    Bertoletti A; Maini MK; Ferrari C
    Antivir Ther; 2010; 15 Suppl 3():15-24. PubMed ID: 21041900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
    Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.